Sébastien Bailly
Sébastien Bailly is an expert in Critical care at Centre Hospitalier Universitaire de Grenoble (France). As of October 2026, ScienceLeadR ranks Sébastien Bailly in the top 1% of experts worldwide for Apnea, Sleep Apnea Syndromes and Respiration Disorders. Sébastien Bailly has authored 397 publications, the most recent in 2026, and is an investigator in 22 clinical trials, 8 of them ongoing. SLR score: 1,453 (community average: 125). How the SLR is computed.
LeadR Profile
Critical care
Subspecialties: Pulmonology - Sleep Medicine Specialty - Neurology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2010 - 2026
Number : 397
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 22
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 10
Ongoing Clinical Trials
8 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A clinical study of zilovertamab vedotin in people with large B cell lymphoma (MK 2140 010) 2024-515566-13-00 — cells, lymphoma, b-cell, lymphoma, lymphoma, large b-cell, diffuse, b-lymphocytes | Phase 3 | Recruiting | 2025 |
| Proof of Concept for Real time Multicentric Monitoring of MRD by PET and ctDNA in Aggressive B Cell Lymphomas NCT07514715 — cells, blood, circulating tumor dna, lymphoma, b-cell, lymphoma, positron-emission tomography, neoplasms, neoplasm, residual, therapeutics, hematologic tests, dna, b-lymphocytes | N/A | Not yet recruiting | 2026 |
| Study evaluating thromboprophylaxis in patients with advanced germ cell tumours of good or intermediate prognosis 2022-502426-41-00 — cells, neoplasms, germ cells, prognosis | Phase 3 | Recruiting | 2023 |
| Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors NCT05874063 — cells, neoplasms, germ cell and embryonal, neoplasms, drug therapy, germ cells, prognosis, chemotherapy | Phase 3 | Recruiting | 2023 |
| Study Consortium for Evaluation of RNPC Program in Obese and Overweight Patients (SCOOP RNPC) NCT05857319 — diabetes mellitus, nutrients, shellfish, clinical protocols, comorbidity, eggs, eating, sleep apnea, obstructive, vitamins, metabolic diseases, pharmaceutical preparations, sleep, non-alcoholic fatty liver disease, meat, cardiovascular diseases, apnea, rehabilitation, diet, mediterranean, diet, food, obesity, vegetables, sleep apnea syndromes, weight loss, therapeutics, meals, overweight, carbohydrates, diabetes mellitus, type 2, lipids | N/A | Not yet recruiting | 2023 |
LeadR Networks
Main global connection map